Officer sold
Stock since the trade -2.0% · S&P 500 -0.7% · to Oct 1Traded 8 days after resultsStock within 3% of its 52-week high
Loading…
Cardinal Health
CAH · NYSE · Health Care Distributors
CAH · NYSE · Health Care Distributors
Health Care Distributors company based in Dublin, Ohio.
Last close, Oct 1, 2026
$230.09
Adjusted for splits and dividends
Last 12 months
+45.7%
S&P 500 +14.3% over the same dates
Market value
$53.5B
Last close × shares outstanding
Bets against the stock: 6.67M shares sold short (2.9% of shares outstanding), -0.7% vs the previous count, 4.6 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
31 sales
$59.6M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2026
$254B
+14.2% vs the year before
Net income, fiscal 2026
$1.71B
As reported in the annual filing
Shares outstanding
233M
As of Jul 31, 2026
In fiscal 2026 the company spent $1.36B buying back its own shares and $491M on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade -2.0% · S&P 500 -0.7% · to Oct 1Traded 8 days after resultsStock within 3% of its 52-week high
Cardinal Health's Chief Accounting Officer sold $523K of Cardinal Health shares. Nobody planned it ahead of time.
Stock since the trade -2.0% · S&P 500 -0.7% · to Oct 1Traded 8 days after resultsStock within 3% of its 52-week high
5,113 → 5,013 shares held−2% of their stake
Cardinal Health's Chief Accounting Officer sold $24K of Cardinal Health shares. Nobody planned it ahead of time.
Stock since the trade -2.1% · S&P 500 -0.5% · to Oct 1Traded 7 days after resultsStock within 3% of its 52-week high
294K → 264K shares held−10% of their stake
The boss of Cardinal Health sold $7.05M of Cardinal Health shares. Nobody planned it ahead of time.
Stock since the trade -2.1% · S&P 500 -0.5% · to Oct 1Traded 7 days after resultsStock within 3% of its 52-week high
315K → 294K shares held−7% of their stake
The boss of Cardinal Health sold $5.02M of Cardinal Health shares. Nobody planned it ahead of time.
Stock since the trade -2.1% · S&P 500 -0.5% · to Oct 1Traded 7 days after resultsStock within 3% of its 52-week high
264K → 248K shares held−6% of their stake
The boss of Cardinal Health sold $3.83M of Cardinal Health shares. Nobody planned it ahead of time.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Short sale volume: 48.1% of the volume reported to FINRA over the last 20 trading days was marked short, close to its 1-year average of 47.1%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
Vanguard Capital Management
Schedule 13G: passive · filed Apr 29, 2026 · 17.6M shares
Wellington Management Group LLP
Schedule 13G: passive · filed Aug 13, 2026 · 14.9M shares
Vanguard Portfolio Management
Schedule 13G: passive · filed Apr 29, 2026 · 13.8M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
46 certified in FY2026 Q3, vs 28 a year earlier. 46 positions in total, median offered wage $111K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
1 approval or clearance and 24 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Last 12 months, adjusted daily closes
Adjusted close went from $157.93 on Oct 1, 2025 to $230.09 on Oct 1, 2026 (+45.7%). Disclosed trades in the last 12 months: 0 insider purchases, 35 insider sales, 2 Congress purchases, 0 Congress sales.